- Home
- NUWE vs TCRT Comparison
NUWE vs TCRT Comparison
Compare NUWE & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- TCRT
- Stock Information
- Founded
- NUWE 1999
- TCRT 1998
- Country
- NUWE United States
- TCRT United States
- Employees
- NUWE N/A
- TCRT N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- TCRT Health Care
- Exchange
- NUWE Nasdaq
- TCRT Nasdaq
- Market Cap
- NUWE 3.9M
- TCRT 3.8M
- IPO Year
- NUWE N/A
- TCRT N/A
- Fundamental
- Price
- NUWE $6.88
- TCRT $4.99
- Analyst Decision
- NUWE Strong Buy
- TCRT
- Analyst Count
- NUWE 1
- TCRT 0
- Target Price
- NUWE $714.00
- TCRT N/A
- AVG Volume (30 Days)
- NUWE 121.9K
- TCRT 48.8K
- Earning Date
- NUWE 08-12-2025
- TCRT 08-13-2025
- Dividend Yield
- NUWE N/A
- TCRT N/A
- EPS Growth
- NUWE N/A
- TCRT N/A
- EPS
- NUWE N/A
- TCRT N/A
- Revenue
- NUWE $8,787,000.00
- TCRT $11,000.00
- Revenue This Year
- NUWE $6.53
- TCRT $5,680,500.00
- Revenue Next Year
- NUWE $51.63
- TCRT N/A
- P/E Ratio
- NUWE N/A
- TCRT N/A
- Revenue Growth
- NUWE N/A
- TCRT 83.33
- 52 Week Low
- NUWE $6.73
- TCRT $1.31
- 52 Week High
- NUWE $197.40
- TCRT $6.90
- Technical
- Relative Strength Index (RSI)
- NUWE 25.34
- TCRT 66.12
- Support Level
- NUWE $7.20
- TCRT $4.72
- Resistance Level
- NUWE $10.08
- TCRT $5.24
- Average True Range (ATR)
- NUWE 0.99
- TCRT 0.46
- MACD
- NUWE 0.64
- TCRT -0.02
- Stochastic Oscillator
- NUWE 10.66
- TCRT 66.89
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.